Condensed Consolidated Statements of Stockholders' Deficit - USD ($)	Total	Elevai Acquisition [Member]	Common Stock [Member]	Common Stock [Member] Elevai Acquisition [Member]	Additional Paid-in Capital [Member]	Additional Paid-in Capital [Member] Elevai Acquisition [Member]	Accumulated Deficit [Member]
Beginning Balance at Dec. 31, 2024	$ (4,712,662)		$ 70		$ 64,158,930		$ (68,871,662)
Beginning Balance (in Shares) at Dec. 31, 2024			696,969
Common Stock issued	1,637,610	$ 660,805	$ 26	$ 4	1,637,584	$ 660,801
Stock shares issued during the period shares			268,840	38,308
Stock-based compensation expense	114,829				114,829
Net Income (Loss)	(1,505,867)	(1,505,867)					(1,505,867)
Ending Balance at Mar. 31, 2025	(3,805,285)		$ 100		66,572,144		(70,377,529)
Ending Balance (in Shares) at Mar. 31, 2025			1,004,117
Beginning Balance at Dec. 31, 2025	(5,866,873)		$ 178		69,909,893		(75,776,944)
Beginning Balance (in Shares) at Dec. 31, 2025			1,781,738
Common Stock issued	190,001	67,742	$ 69		189,932	$ 67,742
Stock shares issued during the period shares			689,656	3,927
Stock-based compensation expense	145,927				145,927
Net Income (Loss)	(1,431,713)	$ (1,431,713)					(1,431,713)
Ending Balance at Mar. 31, 2026	$ (6,894,916)		$ 247		$ 70,313,494		$ (77,208,657)
Ending Balance (in Shares) at Mar. 31, 2026			2,475,321